Sign in

CIK 0001501697

  • Non-accelerated filer
  • Smaller reporting company

X4 Pharmaceuticals, Inc

Sign in to watch
Ticker
XFOR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
273181608
Phone
+1 857-529-8300
Business address
61 NORTH BEACON STREET, 4TH FLOOR, BOSTON, MA, 02134
Former names
Arsanis, Inc.
Open-market buys, last 90 days
$11,884
in 1 filing
Open-market sales, last 90 days
$33,658
in 1 filing

Net −$21,775. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. KIRSKE DAVID −$34K Chief Financial Officer sold 7% of stake
  2. Craig Adam R +$12K Executive Chairman 1 filing
Date Insider Transaction Shares Price Value Owned after
2019-03-13 Ragan Paula President and CEO Grant or award +181,366 181,366
2019-03-13 Ragan Paula President and CEO Grant or award · Stock Option (right to buy) +100,729 100,729
2019-03-13 Ragan Paula President and CEO Grant or award · Stock Option (right to buy) +65,430 65,430
2019-03-13 Ragan Paula President and CEO Grant or award · Stock Option (right to buy) +80,160 80,160
2018-11-27 GRAY MICHAEL President, CEO and CFO Grant or award +250,000 250,000
2018-06-05 MCGUIRE TERRANCE Director Grant or award · Stock Option (right to buy) +10,000 10,000
2018-06-05 SCHULMAN AMY W Director Grant or award · Stock Option (right to buy) +10,000 10,000
2018-06-05 Ross Michael Jay Director Grant or award · Stock Option (right to buy) +10,000 10,000
2018-06-05 Nessi Claudio Director Grant or award · Stock Option (right to buy) +10,000 10,000
2018-06-05 MCGIRR DAVID W J Director Grant or award · Stock Option (right to buy) +10,000 10,000
2018-06-05 GORDON CARL L Director Grant or award · Stock Option (right to buy) +10,000 10,000
2018-06-05 Gerngross Tillman U. Director Grant or award · Stock Option (right to buy) +10,000 10,000
2018-06-05 Clark William D Director Grant or award · Stock Option (right to buy) +10,000 10,000
2018-03-07 GRAY MICHAEL COO and CFO Grant or award · Stock option (right to buy) +110,000 110,000
2018-03-07 Mantus David Chief Development Officer Grant or award · Stock option (right to buy) +50,000 50,000
2018-03-07 Nagy Eszter Chief Scientific Officer Grant or award · Stock option (right to buy) +45,000 45,000
2018-03-07 Russo Rene President and CEO Grant or award · Stock option (right to buy) +160,000 160,000
2018-03-07 STEVENS ANTHONY CHRIS Chief Medical Officer Grant or award · Stock option (right to buy) +50,000 50,000
2017-11-20 EMBL Technology Fund II GmbH & Co. KG 10% owner Conversion +103,278 103,278
2017-11-20 EMBL Technology Fund II GmbH & Co. KG 10% owner Conversion +247,176 350,454

Page 14 of 25 · 490 trades